Vital-Lopez Francisco G, Reifman Jaques, Wallqvist Anders
Department of Defense Biotechnology High Performance Computing Software Applications Institute, Telemedicine and Advanced Technology Research Center, U.S. Army Medical Research and Materiel Command, Fort Detrick, Maryland, United States of America.
PLoS Comput Biol. 2015 Oct 2;11(10):e1004452. doi: 10.1371/journal.pcbi.1004452. eCollection 2015 Oct.
A hallmark of Pseudomonas aeruginosa is its ability to establish biofilm-based infections that are difficult to eradicate. Biofilms are less susceptible to host inflammatory and immune responses and have higher antibiotic tolerance than free-living planktonic cells. Developing treatments against biofilms requires an understanding of bacterial biofilm-specific physiological traits. Research efforts have started to elucidate the intricate mechanisms underlying biofilm development. However, many aspects of these mechanisms are still poorly understood. Here, we addressed questions regarding biofilm metabolism using a genome-scale kinetic model of the P. aeruginosa metabolic network and gene expression profiles. Specifically, we computed metabolite concentration differences between known mutants with altered biofilm formation and the wild-type strain to predict drug targets against P. aeruginosa biofilms. We also simulated the altered metabolism driven by gene expression changes between biofilm and stationary growth-phase planktonic cultures. Our analysis suggests that the synthesis of important biofilm-related molecules, such as the quorum-sensing molecule Pseudomonas quinolone signal and the exopolysaccharide Psl, is regulated not only through the expression of genes in their own synthesis pathway, but also through the biofilm-specific expression of genes in pathways competing for precursors to these molecules. Finally, we investigated why mutants defective in anthranilate degradation have an impaired ability to form biofilms. Alternative to a previous hypothesis that this biofilm reduction is caused by a decrease in energy production, we proposed that the dysregulation of the synthesis of secondary metabolites derived from anthranilate and chorismate is what impaired the biofilms of these mutants. Notably, these insights generated through our kinetic model-based approach are not accessible from previous constraint-based model analyses of P. aeruginosa biofilm metabolism. Our simulation results showed that plausible, non-intuitive explanations of difficult-to-interpret experimental observations could be generated by integrating genome-scale kinetic models with gene expression profiles.
铜绿假单胞菌的一个标志是其形成难以根除的基于生物膜的感染的能力。生物膜比游离的浮游细胞更不易受到宿主炎症和免疫反应的影响,并且具有更高的抗生素耐受性。开发针对生物膜的治疗方法需要了解细菌生物膜特有的生理特性。研究工作已经开始阐明生物膜形成背后的复杂机制。然而,这些机制的许多方面仍然知之甚少。在这里,我们使用铜绿假单胞菌代谢网络的基因组规模动力学模型和基因表达谱来解决有关生物膜代谢的问题。具体而言,我们计算了已知生物膜形成改变的突变体与野生型菌株之间的代谢物浓度差异,以预测针对铜绿假单胞菌生物膜的药物靶点。我们还模拟了生物膜和静止生长阶段浮游培养物之间基因表达变化所驱动的代谢改变。我们的分析表明,重要的生物膜相关分子的合成,如群体感应分子铜绿假单胞菌喹诺酮信号和胞外多糖Psl,不仅通过其自身合成途径中基因的表达来调节,还通过竞争这些分子前体的途径中生物膜特异性基因的表达来调节。最后,我们研究了为什么邻氨基苯甲酸降解缺陷的突变体形成生物膜的能力受损。与之前认为这种生物膜减少是由能量产生减少引起的假设不同,我们提出源自邻氨基苯甲酸和分支酸的次生代谢物合成失调才是损害这些突变体生物膜的原因。值得注意的是,通过我们基于动力学模型的方法获得的这些见解是以前对铜绿假单胞菌生物膜代谢的基于约束的模型分析无法获得的。我们的模拟结果表明,通过将基因组规模动力学模型与基因表达谱相结合,可以对难以解释的实验观察结果产生合理的、非直观的解释。